6.
Feenaughty L, Tjaden K, Benedict R, Weinstock-Guttman B
. Speech and pause characteristics in multiple sclerosis: a preliminary study of speakers with high and low neuropsychological test performance. Clin Linguist Phon. 2013; 27(2):134-51.
PMC: 5554953.
DOI: 10.3109/02699206.2012.751624.
View
7.
Archibald C, Fisk J
. Information processing efficiency in patients with multiple sclerosis. J Clin Exp Neuropsychol. 2000; 22(5):686-701.
DOI: 10.1076/1380-3395(200010)22:5;1-9;FT686.
View
8.
Sepulcre J, Peraita H, Goni J, Arrondo G, Martincorena I, Duque B
. Lexical access changes in patients with multiple sclerosis: a two-year follow-up study. J Clin Exp Neuropsychol. 2010; 33(2):169-75.
DOI: 10.1080/13803395.2010.499354.
View
9.
Arnett P, Smith M, Barwick F, Benedict R, Ahlstrom B
. Oralmotor slowing in multiple sclerosis: relationship to neuropsychological tasks requiring an oral response. J Int Neuropsychol Soc. 2008; 14(3):454-62.
DOI: 10.1017/S1355617708080508.
View
10.
De Looze C, Moreau N, Renie L, Kelly F, Ghio A, Rico A
. Effects of cognitive impairment on prosodic parameters of speech production planning in multiple sclerosis. J Neuropsychol. 2017; 13(1):22-45.
DOI: 10.1111/jnp.12127.
View
11.
Lippa S, Davis R
. Inhibition/switching is not necessarily harder than inhibition: an analysis of the D-KEFS color-word interference test. Arch Clin Neuropsychol. 2010; 25(2):146-52.
DOI: 10.1093/arclin/acq001.
View
12.
Swets B, DeSmet T, Hambrick D, Ferreira F
. The role of working memory in syntactic ambiguity resolution: a psychometric approach. J Exp Psychol Gen. 2007; 136(1):64-81.
DOI: 10.1037/0096-3445.136.1.64.
View
13.
Friedova L, Rusz J, Motyl J, Srpova B, Vodehnalova K, Andelova M
. Slowed articulation rate is associated with information processing speed decline in multiple sclerosis: A pilot study. J Clin Neurosci. 2019; 65:28-33.
DOI: 10.1016/j.jocn.2019.04.018.
View
14.
Ontaneda D, Cohen J, Amato M
. Clinical outcome measures for progressive MS trials. Mult Scler. 2017; 23(12):1627-1635.
DOI: 10.1177/1352458517729465.
View
15.
Baylor C, Yorkston K, Bamer A, Britton D, Amtmann D
. Variables associated with communicative participation in people with multiple sclerosis: a regression analysis. Am J Speech Lang Pathol. 2009; 19(2):143-53.
PMC: 2873072.
DOI: 10.1044/1058-0360(2009/08-0087).
View
16.
Nikki Arrington C, Kulesz P, Francis D, Fletcher J, Barnes M
. The Contribution of Attentional Control and Working Memory to Reading Comprehension and Decoding. Sci Stud Read. 2023; 18(5):325-346.
PMC: 9891492.
DOI: 10.1080/10888438.2014.902461.
View
17.
Langdon D, Tomic D, Penner I, Calabrese P, Cutter G, Haring D
. Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 2021; 28(12):4135-4145.
PMC: 9292292.
DOI: 10.1111/ene.15081.
View
18.
DeLuca J, Chiaravalloti N, Sandroff B
. Treatment and management of cognitive dysfunction in patients with multiple sclerosis. Nat Rev Neurol. 2020; 16(6):319-332.
DOI: 10.1038/s41582-020-0355-1.
View
19.
Benedict R, Morrow S, Guttman B, Cookfair D, Schretlen D
. Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. J Int Neuropsychol Soc. 2010; 16(5):829-35.
DOI: 10.1017/S1355617710000688.
View
20.
Chan D, Binks S, Nicholas J, Frost C, Cardoso M, Ourselin S
. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. Lancet Neurol. 2017; 16(8):591-600.
PMC: 5507768.
DOI: 10.1016/S1474-4422(17)30113-8.
View